ADAM17 selectively activates the IL‐6 trans‐signaling/ERK MAPK axis in KRAS‐addicted lung cancer

Mohamed I. Saad(Hudson Institute of Medical Research), Brendan J. Jenkins(Monash University)
EMBO Molecular Medicine
March 4, 2019
Cited by 139


Related Papers